
March 3, 2025
Tofacitinib 5 mg (Tofacent) Medicine – A Global Perspective
Tofacitinib 5 mg, marketed under the brand name Tofacent, is an advanced oral medication widely used in the management of autoimmune diseases such as rheumatoid arthritis (RA), psoriatic arthritis (PsA), and ulcerative colitis (UC). As a Janus kinase (JAK) inhibitor, Tofacitinib plays a crucial role in modulating the immune response and reducing inflammation, offering relief…